Application Nr Approved Date Route Status External Links
ANDA078332 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Carvedilol Is An Alpha/beta-Adrenergic Blocking Agent Indicated For The Treatment Of: Left Ventricular Dysfunction Following Myocardial Infarction In Clinically Stable Patients (1.2) Hypertension (1.3) 1.2 Left Ventricular Dysfunction Following Myocardial Infarction Carvedilol Tablets, Usp Are Indicated To Reduce Cardiovascular Mortality In Clinically Stable Patients Who Have Survived The Acute Phase Of A Myocardial Infarction And Have A Left Ventricular Ejection Fraction Of ≤40% (With Or Without Symptomatic Heart Failure) [See Clinical Studies (14.2) ] . 1.3 Hypertension Carvedilol Tablets, Usp Are Indicated For The Management Of Essential Hypertension [See Clinical Studies (14.3 , 14.4) ] . It Can Be Used Alone Or In Combination With Other Antihypertensive Agents, Especially Thiazide-Type Diuretics [See Drug Interactions (7.2) ] .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Carvedilol CARVEDILOL ZINC1530579

Comments